Showing 721 - 740 results of 1,139 for search '"preclinical"', query time: 0.09s Refine Results
  1. 721
  2. 722

    Natural killer cell engagers for cancer immunotherapy by Shahryar Khoshtinat Nikkhoi, Geng Li, Arash Hatefi, Arash Hatefi

    Published 2025-01-01
    “…This review article critically examines the strategies for engineering bi-, tri-, and multi-specific NKCEs for cancer immunotherapy, providing an in-depth analysis of the latest advancements in NKCE platform technologies currently under development by pharmaceutical and biotech companies and discussing the preclinical and clinical progress of these products. …”
    Get full text
    Article
  3. 723

    Gut–brain axis and neuropsychiatric health: recent advances by Ceymi Doenyas, Gerard Clarke, Renáta Cserjési

    Published 2025-01-01
    “…The studies described in this Collection support and expand on the observations from previous preclinical and clinical investigations, while also providing essential novel insights that can drive discovery into previously unexplored avenues of brain-gut-microbiome interactions in health and disease.…”
    Get full text
    Article
  4. 724

    Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System by Bella S. Guerrouahen, Heba Sidahmed, Asma Al Sulaiti, Moza Al Khulaifi, Chiara Cugno

    Published 2019-01-01
    “…In the present review, we focus on the suppressive effect that MSCs exert on the immune system and highlight the significance of in vitro preconditioning and its use in preclinical studies. We discuss the clinical aspects of using MSCs as an immunomodulatory treatment. …”
    Get full text
    Article
  5. 725

    Update on the Treatment of Diabetic Retinopathy by Jennifer L. Wilkinson-Berka, Antonia G. Miller

    Published 2008-01-01
    “…This review examines evidence from preclinical and clinical studies that shows that targeting inhibition of the renin-angiotensin system, vascular endothelial growth factor, corticosteroids, protein kinase C, growth hormone, and advanced glycation end-products are potential treatments for DR.…”
    Get full text
    Article
  6. 726

    Feasibility of NaF PET/CT and MRI for Noninvasive In Vivo Quantification of Knee Pathophysiological Bone Metabolism in a Canine Model of Post-traumatic Osteoarthritis by Maria I. Menendez DVM, PhD, Bianca Hettlich DrMedVet, Lai Wei PhD, Michael V. Knopp MD, PhD

    Published 2017-07-01
    “…Moreover, it brings a novel musculoskeletal preclinical imaging methodology that can provide unique insights into PTOA pathophysiology.…”
    Get full text
    Article
  7. 727

    Assessment of the Association between In Vivo Corneal Morphogeometrical Changes and Keratoconus Eyes with Severe Visual Limitation by J. S. Velázquez, F. Cavas, J. Alió del Barrio, D. G. Fernández-Pacheco, J. Alió

    Published 2019-01-01
    “…This observational case series study evaluated new objective indices in 50 healthy and 30 KC corneas, following a validated protocol created by our research group, which has been previously used for diagnosis and characterization of KC in asymptomatic (preclinical) and mild visually impaired eyes. Results show a statistically significant reduction of corneal volume and an increase of total corneal area in the severe KC group, being anterior and posterior corneal surfaces minimum thickness points the best correlated parameters, although with no discrimination between groups. …”
    Get full text
    Article
  8. 728

    Dual Roles of IL-27 in Cancer Biology and Immunotherapy by Marina Fabbi, Grazia Carbotti, Silvano Ferrini

    Published 2017-01-01
    “…Several pieces of evidence, obtained in preclinical tumor models, indicated that IL-27 has a potent antitumor activity, related not only to the induction of tumor-specific Th1 and cytotoxic T lymphocyte (CTL) responses but also to direct inhibitory effects on tumor cell proliferation, survival, invasiveness, and angiogenic potential. …”
    Get full text
    Article
  9. 729

    Assessing Medical Students’ Learning Style Preferences at Kabale University Medical School, Uganda. by Muhaise, Hussein, Businge, Phelix Mbabazi, Ssemaluulu, Paul, Kyomugisha, Patricia

    Published 2024
    “…Relatively, t-test results showed significant (p < 0.05) differences in learning styles between preclinical and clinical students. However, the t-test results for gender factors for all the learning dimensions were insignificant (p > 0.05). …”
    Get full text
    Article
  10. 730
  11. 731
  12. 732

    Mice develop obesity and lose myocardial metabolic flexibility months after exertional heat stroke by Jamal M. Alzahrani, Ashley J. Smuder, Bryce J. Gambino, Cristina Delgado, Michael T. Rua, Ryan N. Montalvo, Finleigh P. Fitton, Deborah A. Morse, Thomas L. Clanton

    Published 2025-01-01
    “…We tested whether a single exposure to acute heat illness, using a preclinical mouse model of exertional heat stroke (EHS), can induce late-emerging health disorders that progress into chronic disease. …”
    Get full text
    Article
  13. 733

    Therapeutic potential of Garlic (Allium sativum L.) on new models of asthma immune pathobiology: A review by VR Bataduwaarachchi, DCJ Liyanage, SMN Hansanie, HDSM Perera, LG D'Cruz

    Published 2025-02-01
    “…Aims of the study: This review aims to explore the potential effects of garlic (Allium sativum L.) on the immune pathobiology of new asthma models and to provide guidance and comprehensive reference material for preclinical and clinical studies. Materials and methods: A comprehensive literature review was conducted in PubMed, Medline Scopus, and Google Scholar. …”
    Get full text
    Article
  14. 734

    Targeting fucosyltransferase FUT8 as a prospective therapeutic approach for DLBCL by Hao Xu, Qi Li, Yuchen Zhang, Chuan He, Xinyun Zhang, Zhiming Wang, Meifang Zhao, Yali Chai, Wenzhuo Zhuang, Bingzong Li

    Published 2025-01-01
    “…Furthermore, our screening efforts involving clinical and preclinical drugs unveiled a compelling synergistic effect between chidamide and morusinol. …”
    Get full text
    Article
  15. 735

    Non-enzymatic protein targeting agents as a promising strategy for cancer treatment by Madison Ambrose, Jeremy Lee, Aleem Syed, Zamal Ahmed, Guang Peng

    Published 2025-01-01
    “…To discover this class of new anticancer drugs, two molecular approaches targeting the non-enzymatic activities of proteins have shown promising experimental, preclinical, and clinical results. In the first approach, selective agents known as PROteolysis-TArgeting Chimeras (PROTACs) employ innate endogenous protein degradation machinery in cells to proteolyze the targeted protein. …”
    Get full text
    Article
  16. 736

    Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells by Shiming Ye, Melvin I. Fox, Nicole A. Belmar, Mien Sho, Debra T. Chao, Donghee Choi, Yuni Fang, Vivian Zhao, Stephen F. Keller, Gary C. Starling, Patricia A. Culp

    Published 2017-01-01
    “…Conditioned media from enavatuzumab-treated tumor cells contained elevated levels of chemokines, which might be responsible for enavatuzumab-triggered effector cell migration. These preclinical studies demonstrate that enavatuzumab can exert its potent antitumor activity by actively recruiting and activating myeloid effectors to kill tumor cells. …”
    Get full text
    Article
  17. 737

    Towards autonomous robotic THz-based in vivo skin sensing: the PicoBot by Anubhav Dogra, Dominic Jones, Arturo Ignacio Hernandez Serrano, Shruti Chakraborty, Jacob Joshua Young, Benjamin George Page, Joseph Hardwicke, Pietro Valdastri, Emma Pickwell-MacPherson

    Published 2025-02-01
    “…The tests conducted validate the preclinical feasibility of the concept along with the robustness and advantages of using the PicoBot, compared to a manual measurement setup.…”
    Get full text
    Article
  18. 738

    Leaflet: Operative Steps for Interventional Studies in Neuroscience by Maria Meringolo, Sergio Delle Monache, Giuseppina Martella, Antonella Peppe

    Published 2024-12-01
    “…Notably, neuroscience drug development encounters distinct challenges, including the complex nature of diseases, limitations imposed by the blood–brain barrier, the absence of reliable predictive preclinical models, and regulatory hurdles. Ethical and safety considerations are pivotal due to the potential cognitive and motor effects of CNS-active drugs. …”
    Get full text
    Article
  19. 739

    AI‐Powered Multimodal Modeling of Personalized Hemodynamics in Aortic Stenosis by Caglar Ozturk, Daniel H. Pak, Luca Rosalia, Debkalpa Goswami, Mary E. Robakowski, Raymond McKay, Christopher T. Nguyen, James S. Duncan, Ellen T. Roche

    Published 2025-02-01
    “…Abstract Aortic stenosis (AS) is the most common valvular heart disease in developed countries. High‐fidelity preclinical models can improve AS management by enabling therapeutic innovation, early diagnosis, and tailored treatment planning. …”
    Get full text
    Article
  20. 740

    CRISPR-Cas9 in basic and translational aspects of cancer therapy by Maryam Samareh Salavatipour, Zahra Poursalehi, Negin Hosseini Rouzbahani, Sohaib Mohammadyar, Mohammad Vasei

    Published 2024-11-01
    “…Results: We have defined the basics of this technology and then mentioned some clinical and preclinical studies using this technology in the treatment of a variety of solid tumors as well as hematologic neoplasms. …”
    Get full text
    Article